Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 3601 AL 3615

What, When and How to Measure-Peripheral Biomarkers in Therapy of Huntington's Disease

Przybyl L, Wozna-Wysocka M, Kozlowska E, Fiszer A.

Int J Mol Sci. 2021 Feb 4;22(4):1561. doi: 10.3390/ijms22041561.

Oligodendroglial Heterogeneity in Neuropsychiatric Disease

Bøstrand SMK, Williams A.

Life (Basel). 2021 Feb 6;11(2):125. doi: 10.3390/life11020125.

Carbohydrate-Restricted Diet: A Successful Strategy for Short-Term Management in Youth with Severe Obesity-An Observational Study

Pauley M, Mays C, Bailes JR Jr, Schwartzman ML, Castle M, McCoy M, Patick C, Preston D, Nudelman MJR, Denning KL, Bellner L, Werthammer J.

Metab Syndr Relat Disord. 2021 Jun;19(5):281-287. doi: 10.1089/met.2020.0078. Epub 2021 Feb 9.

Transient bilateral chorea secondary to digoxin toxicity in a female with acute kidney injury: a case report

Mannion J, Tariq S, Owens P.

Eur Heart J Case Rep. 2021 Feb 4;5(2):ytab022. doi: 10.1093/ehjcr/ytab022. eCollection 2021 Feb.

Dysregulation of PGC-1α-Dependent Transcriptional Programs in Neurological and Developmental Disorders: Therapeutic Challenges and Opportunities

McMeekin LJ, Fox SN, Boas SM, Cowell RM.

Cells. 2021 Feb 9;10(2):352. doi: 10.3390/cells10020352.

Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives

Behl T, Kaur G, Sehgal A, Bhardwaj S, Singh S, Buhas C, Judea-Pusta C, Uivarosan D, Munteanu MA, Bungau S.

Int J Mol Sci. 2021 Jan 30;22(3):1413. doi: 10.3390/ijms22031413.

False-negative tests in Huntington's disease: A new variant within primer hybridization site

Dulski J, Sulek A, Krygier M, Radziwonik W, Slawek J.

Eur J Neurol. 2021 Jun;28(6):2103-2105. doi: 10.1111/ene.14772. Epub 2021 Mar 8.

DNA Repair in Huntington's Disease and Spinocerebellar Ataxias: Somatic Instability and Alternative Hypotheses

Maiuri T, Hung CLK, Suart C, Begeja N, Barba-Bazan C, Peng Y, Savic N, Wong T, Truant R.

J Huntingtons Dis. 2021;10(1):165-173. doi: 10.3233/JHD-200414.

Modifiers of CAG/CTG Repeat Instability: Insights from Mammalian Models

Wheeler VC, Dion V.

J Huntingtons Dis. 2021;10(1):123-148. doi: 10.3233/JHD-200426.

Huntington's Disease Pathogenesis: Two Sequential Components

Hong EP, MacDonald ME, Wheeler VC, Jones L, Holmans P, Orth M, Monckton DG, Long JD, Kwak S, Gusella JF, Lee JM.

J Huntingtons Dis. 2021;10(1):35-51. doi: 10.3233/JHD-200427.

DNA Mismatch Repair and its Role in Huntington's Disease

Iyer RR, Pluciennik A.

J Huntingtons Dis. 2021;10(1):75-94. doi: 10.3233/JHD-200438.

What is the Pathogenic CAG Expansion Length in Huntington's Disease?

Donaldson J, Powell S, Rickards N, Holmans P, Jones L.

J Huntingtons Dis. 2021;10(1):175-202. doi: 10.3233/JHD-200445.

FAN1, a DNA Repair Nuclease, as a Modifier of Repeat Expansion Disorders

Deshmukh AL, Porro A, Mohiuddin M, Lanni S, Panigrahi GB, Caron MC, Masson JY, Sartori AA, Pearson CE.

J Huntingtons Dis. 2021;10(1):95-122. doi: 10.3233/JHD-200448.

Huntington's Disease: New Frontiers in Therapeutics

Pan L, Feigin A.

Curr Neurol Neurosci Rep. 2021 Feb 14;21(3):10. doi: 10.1007/s11910-021-01093-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias